Ausgabe 1/2024
Inhalt (18 Artikel)
Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis
Neslihan Nisa Gecici, Muhammet Enes Gurses, Brandon Kaye, Natasha L. Frontera Jimenez, Chandler Berke, Elif Gökalp, Victor M. Lu, Michael E. Ivan, Ricardo J. Komotar, Ashish H. Shah
Assessment of multimodal treatment options in recurrent and persistent acromegaly: a systematic review and meta-analysis
Seyed Farzad Maroufi, Manijeh Assar, MirHojjat Khorasanizadeh, Fatemeh Mahdavi Sabet, Mohammadmahdi Sabahi, Rocco Dabecco, Badih Adada, Gabriel Zada, Hamid Borghei-Razavi
Superficial meningioma with bone involvement: surgical strategies and clinical outcomes
Gang Li, Qilong Tian, Shoujie Wang, Kailu Li, Yu Zhang, Qing Cai
Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status
Johanna Jost, Klaus Völker, Ralf Brandt, Walter Stummer, Steffi Urbschat, Ralf Ketter, Dorothee Wiewrodt, Rainer Wiewrodt, Maren Kloss, Nora Hansel, Irmtraud Früchte, Ross Julian, Lothar Thorwesten, Joachim Gerß, Andreas Faldum, Joachim Oertel, Philipp Lepper, Kathleen Jetschke, Sylvia Rekowski, Carolin Weiss Lucas, Sophia Kochs, Freerk Baumann
Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status
Johanna Jost, Klaus Völker, Ralf Brandt, Walter Stummer, Steffi Urbschat, Ralf Ketter, Dorothee Wiewrodt, Rainer Wiewrodt, Maren Kloss, Nora Hansel, Irmtraud Früchte, Ross Julian, Lothar Thorwesten, Joachim Gerß, Andreas Faldum, Joachim Oertel, Philipp Lepper, Kathleen Jetschke, Sylvia Rekowski, Carolin Weiss Lucas, Sophia Kochs, Freerk Baumann
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers
Christoph Straube, Stephanie E. Combs, Denise Bernhardt, Jens Gempt, Bernhard Meyer, Claus Zimmer, Friederike Schmidt-Graf, Peter Vajkoczy, Arne Grün, Felix Ehret, Daniel Zips, David Kaul
Effects of cognitive-motor intervention for pediatric posterior fossa tumor survivors: results of a pilot study
Vladimir N. Kasatkin, Elizaveta N. Romanova, Elena V. Glebova, Alena A. Deviaterikova, Vera V. Tolchennikova, Anastasia A. Sharapkova, Piruza A. Manukyan, Nadezhda M. Karpova, Roza A. Sarkisyan, Alexander F. Karelin
Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse
Elissa Tong, Patrick Horsley, Helen Wheeler, Matthew Wong, Venkatesha Venkatesha, Joseph Chan, Marina Kastelan, Michael Back
The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database
Ping Zhu, Pavel S. Pichardo-Rojas, Antonio Dono, Nitin Tandon, Constantinos G. Hadjipanayis, Mitchel S. Berger, Yoshua Esquenazi
Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy
Natsuko Kondo, Tadatoshi Kinouchi, Manabu Natsumeda, Juntaro Matsuzaki, Eishu Hirata, Yoshinori Sakurai, Masayasu Okada, Minoru Suzuki
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches
Elad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, Sylvia Adams, Brandon Santhumayor, Ying Meng, Zane Schnurman, Bernadine R. Donahue, Kenneth Bernstein, Cordelia Orillac, Rishitha Bollam, Maryann J. Kwa, Marleen Meyers, Ruth Oratz, Yelena Novik, Joshua S. Silverman, David H. Harter, John G. Golfinos, Douglas Kondziolka
Sex differences in adverse events in Medicare individuals ≥ 66 years of age post glioblastoma treatment
Mantas Dmukauskas, Gino Cioffi, Kristin A. Waite, Andrew E. Sloan, Corey Neff, Mackenzie Price, Quinn T. Ostrom, Jill S. Barnholtz-Sloan
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Adrian J. Rodrigues, Sophia B. Chernikova, Yuelong Wang, Thy T. H. Trinh, David E. Solow-Cordero, Ludmila Alexandrova, Kerriann M. Casey, Elizabeth Alli, Abhishek Aggarwal, Tyler Quill, Ashley K. Koegel, Brian J. Feldman, James M. Ford, Melanie Hayden-Gephart
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor
Shizun Wang, Dan Zhang, Jialin Wang, Xiaojiao Peng, Hailang Sun, Yuanqi Ji, Zhenli Yang, Xiaocui Bian, Yuhong Hou, Ming Ge, Yuqin Liu
Perioperative psychological distress in patients with intracranial tumors; a single center study
Michael-Karl Fehrenbach, Florian Wilhelmy, Tim Wende, Erdem Güresir, Johannes Kasper
Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition
Wietse Geens, Nathalie Vanlaer, Lynn Nijland, Sven Van Laere, Julia Katharina Schwarze, Michaël Bruneau, Bart Neyns, Anne Rogiers, Johnny Duerinck
Gamma knife radiosurgery for clival metastasis: case series and systematic review
Sakibul Huq, Regan M. Shanahan, Samuel Adida, Othman Bin-Alamer, Hussam Abou-Al-Shaar, Ajay Niranjan, Constantinos G. Hadjipanayis, L. Dade Lunsford
Elevating the findings by substituting in “ISarcoPRM”
Ahmad Jasem Abdulsalam, Murat Kara, Levent Özçakar